Blog

Screen Shot 2017-10-12 at 10.06.15 AM

The National Liberty Museum honored Stephen and Sandra Sheller as “2017 Heroes of Liberty” at the 18th Annual Glass Auction & Gala held on October 7, 2017 at the Sheraton Philadelphia Downtown Hotel.
Supreme Court of the United States

Risperdal litigation in Philadelphia courts have increased significantly this year and the trend is likely to continue. Mass torts against Janssen, a Johnson & Johnson subsidiary, over it’s antipsychotic drug Risperdal has nearly
Sheller Breast Implant

In 1984 a federal jury in San Francisco found Dow Corning’s breast implants were “defectively designed and manufactured.” Maria Stern was awarded $1.7 M after internal corporate memos and studies show that Dow
Sheller Risperdal interview

In ‘For Plaintiffs Bar, Taking on J&J Means Battling a Shadow Foe,’ Law.com’s Amanda Bronstad reports on the “intimate relationship” between Johnson & Johnson (J&J) and the U.S. Chamber of Commerce (the Chamber). The U.S. Chamber
Breast Implant Associated Lymphoma Cropped

A new type of lymphoma called breast implant-associated anapestic large-cell lymphoma has medical authorities finally agreeing that the prosthetics can cause disease. The first recognized case was in 1997, however a warning from
Screen Shot 2017-06-09 at 4.58.00 PM

Sheller PC’s $70 Million Risperdal win hits #1 on the Top 50 Verdicts in Pennsylvania in 2016. In the case A.Y., Pro Ami v. Janssen Pharmaceuticals, Inc., a jury found for an autistic Tennessee boy
Steve name on Phillies field display with CS Lewis quote-1 copy

Stephen A. Sheller, who has served on the board of trustees of Drexel University since 2003 and on Drexel’s Thomas R. Kline School of Law advisory board, will receive an honorary degree at
IVC,Filter,lawsuit,injury,lawyer,law,firm,stroke,death

Sheller PC is currently representing multiple victims nationwide injured by IVC filters. Below are just a few.  Currently 3,500 IVC Filter lawsuits are pending in the U.S. A Texas man will have to live
Various tablets

Patients with type 2 diabetes taking Johnson & Johnson’s drug Invokana are twice as likely to have a leg and foot amputation than patients given a placebo, two clinical trial show. The FDA
Supreme Court of the United States

High Court Won’t Hear Dispute Challenging FDA Over J&J Drug Supreme Court won’t weigh in on whether law firm can sue FDA over drug labeling Circumstances in which third parties can sue over